Drug development in oncology assisted by noninvasive optical imaging.

[1]  Sancey Lucie,et al.  Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  L. Sancey,et al.  Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model. , 2008, Cancer biotherapy & radiopharmaceuticals.

[3]  Rebecca Richards-Kortum,et al.  Optical contrast agents and imaging systems for detection and diagnosis of cancer , 2008, International journal of cancer.

[4]  Keith Guy,et al.  The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. , 2008, Toxicology and applied pharmacology.

[5]  H. Messmann,et al.  Indications and techniques for lower intestinal endoscopy. , 2008, Best practice & research. Clinical gastroenterology.

[6]  Werner Jaschke,et al.  Molecular imaging with nanoparticles: giant roles for dwarf actors , 2008, Histochemistry and Cell Biology.

[7]  D. Boturyn,et al.  Synthesis and Biological Characterisation of Targeted Pro‐Apoptotic Peptide , 2008, Chembiochem : a European journal of chemical biology.

[8]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[10]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[11]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer , 2008, Clinical Cancer Research.

[12]  Milton V. Marshall,et al.  Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.

[13]  G. Denardo,et al.  Editorial: 2008: State of Affairs for Cancer Biotherapy & Radiopharmaceuticals , 2008 .

[14]  S. Anandasabapathy.  Endoscopic imaging: emerging optical techniques for the detection of colorectal neoplasia , 2008, Current opinion in gastroenterology.

[15]  G. Luker,et al.  Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.

[16]  J.-M. Dinten,et al.  From bench-top small animal diffuse optical tomography towards clinical imaging , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[17]  J. Coll,et al.  Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice , 2007, Gene Therapy.

[18]  D. Boturyn,et al.  Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. , 2007, Anti-cancer agents in medicinal chemistry.

[19]  L. Sancey,et al.  In vivo imaging of tumour angiogenesis in mice with the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  P. Peltié,et al.  Noncontact fluorescence diffuse optical tomography of heterogeneous media. , 2007, Applied optics.

[21]  D. Boturyn,et al.  In vivo optical imaging of integrin αV-β3 in mice using multivalent or monovalent cRGD targeting vectors , 2007, Molecular Cancer.

[22]  P. Perriat,et al.  Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.

[23]  Martial Guillaud,et al.  Real-time reflectance confocal microscopy: comparison of two-dimensional images and three-dimensional image stacks for detection of cervical precancer. , 2007, Journal of biomedical optics.

[24]  D. Boturyn,et al.  Noninvasive Optical Imaging of Ovarian Metastases Using Cy5-labeled RAFT-c(-RGDfK-)4 , 2006, Molecular imaging.

[25]  Rebecca Richards-Kortum,et al.  Optical molecular imaging agents for cancer diagnostics and therapeutics. , 2006, Nanomedicine.

[26]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[27]  Jean-Luc Coll,et al.  New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  B. Tromberg,et al.  Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy , 2005, Breast Cancer Research.

[29]  J. Bading,et al.  Integrin αβ3-Targeted Imaging of Lung Cancer , 2005 .

[30]  J. Ripoll,et al.  Experimental determination of photon propagation in highly absorbing and scattering media. , 2005, Journal of the Optical Society of America. A, Optics, image science, and vision.

[31]  Bartek Rajwa.  Modern Confocal Microscopy , 2005, Current protocols in cytometry.

[32]  Andras Czirok,et al.  αvβ3 integrin-dependent endothelial cell dynamics in vivo , 2004 .

[33]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[34]  Jean-Luc Coll,et al.  Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.

[35]  A. Saven,et al.  Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  David A. Cheresh,et al.  Get a ligand, get a life: integrins, signaling and cell survival , 2002, Journal of Cell Science.

[37]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[38]  G. Davis,et al.  Integrin expression in human melanoma cells with differing invasive and metastatic properties , 1992, Clinical & Experimental Metastasis.

[39]  M. Hendrix,et al.  Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Cheresh,et al.  Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. , 1991, The Journal of clinical investigation.

[41]  Anne Koenig,et al.  In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography. , 2008, Journal of biomedical optics.

[42]  J. Bading,et al.  Integrin alpha v beta 3-targeted imaging of lung cancer. , 2005, Neoplasia.

[43]  András Czirók,et al.  alphavbeta3 integrin-dependent endothelial cell dynamics in vivo. , 2004, Development.

[44]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[45]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[46]  R. Weissleder.  Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[47]  A. Miwa,et al.  Vascular integrin beta 3 and its relation to pulmonary metastasis of colorectal carcinoma. , 2001, Anticancer research.